Comparing the Ceriter Stride One Smart Insole With Gait Measurements on the GRAIL in People With Neurological Conditions

What this Trial Is About

Researchers are evaluating how well Ceriter Stride-One pressure-sensitive smart insoles measure walking patterns in people with neurological conditions such as stroke, traumatic brain injury, acquired brain injury, or incomplete spinal cord injury. This trial compares gait data from these insoles to measurements taken by the advanced GRAIL system, a laboratory setup that captures detailed walking parameters. The goal is to determine if the insoles provide accurate data in real-life walking environments, beyond the lab setting. Participants will wear the Ceriter Stride-One insoles while walking on the GRAIL treadmill, where their gait parameters like stance phase and swing phase durations will be recorded by both the insoles and the GRAIL system. The study involves a 5-week training period with sessions twice a week, each lasting 30 minutes on the treadmill. Before and after this training, participants walk for about 2 minutes on the treadmill for data collection to compare the insoles' measurements with those of the GRAIL system. During the study, participants must be able to walk independently for at least six minutes and weigh less than 120 kg due to treadmill safety limits. Researchers measure gait parameters including speed, step width, step length, and the durations of stance and swing phases. The comparison focuses on how accurately the insoles track these parameters compared to the instrumented treadmill with 3D motion capture. This information aims to support future use of the insoles to monitor walking in everyday environments. Total participation spans the 5-week training and measurement periods.

Comparing the Ceriter Stride One, a Pressure-sensitive Smart Insole, With Gait Parameters Measured on the GRAIL in Neurological Populations